William Gruenloh

Human Mesenchymal Stem Cells Genetically Engineered to Overexpress Brain-derived Neurotrophic Factor Improve Outcomes in Huntington's Disease Mouse Models

Kari Pollock, Heather Dahlenburg, Haley Nelson et al. · Molecular Therapy · 2016 · 163 citations · Full text

Characterization and <i>In Vivo</i> Testing of Mesenchymal Stem Cells Derived from Human Embryonic Stem Cells

William Gruenloh, Amal Kambal, Claus S. Søndergaard et al. · Tissue Engineering Part A · 2011 · 89 citations

Preclinical evaluation of mesenchymal stem cells overexpressing VEGF to treat critical limb ischemia

Julie R. Beegle, Nataly L. Magner, Stefanos Kalomoiris et al. · Molecular Therapy — Methods & Clinical Development · 2016 · 75 citations · Full text

Cell Therapy, Immunology, Biomedical Engineering +18

Generation of HIV-1 Resistant and Functional Macrophages From Hematopoietic Stem Cell–derived Induced Pluripotent Stem Cells

Amal Kambal, Gaela Mitchell, Whitney Cary et al. · Molecular Therapy · 2010 · 73 citations · Full text

Allele-Specific Reduction of the Mutant Huntingtin Allele Using Transcription Activator-Like Effectors in Human Huntington's Disease Fibroblasts

Kyle D. Fink, Peter Deng, Josh Gutierrez et al. · Cell Transplantation · 2016 · 72 citations · Full text

Genetics, Allele-specific Reduction, Tale Proteins +20